Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor (NCT07681375)

🧪 Interventions in This Study

• Basal insulin (DRUG)
• Dexcom Continuous Glucose Monitoring (CGM) (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• San Diego Family Care (SDFC) — San Diego, California

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Type 2 Diabetes

• Continuous Glucose Monitoring System Feasibility in Youth With T2D — San Francisco, California
• Diabetes Nutrition Education and Healthy Food Resource for AIANs With T2D — Oklahoma City, Oklahoma
• Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus — Minneapolis, Minnesota
• Diabetes Medical Nutrition Therapy in Southeastern African American Women — Nashville, Tennessee
• E3 Diabetes - Closing the Gap in Diabetes Control — Chicago, Illinois
• Recreational Basketball to Increase Participation in Diabetes Prevention — Atlanta, Georgia

Explore by condition: All Type 2 Diabetes clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.